Portfolio company
Elitra
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This genomics company developed antimicrobial compounds targeting essential gene products of pathogenic organisms for the pharmaceutical and biotechnology industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Generare
This company develops a discovery platform that generates molecular data from microbial genomes for pharmaceutical and crop protection companies to advance drug and product development.
Discuva
This biotechnology company develops novel antibiotics to treat multi-drug resistant bacterial infections for pharmaceutical partners and healthcare providers.
SelectX Pharmaceuticals
This biopharmaceutical company develops small molecule antimicrobials and therapeutics for unmet medical needs using a genetic chemistry platform for patients with infectious diseases.
Elion Therapeutics
This biotechnology company develops antifungal medicines to prevent and treat life-threatening infections in immunocompromised patients, such as organ transplant and oncology recipients.
Calixa Therapeutics
This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.
Arpida
This company develops antimicrobial drugs and broad-spectrum antibiotics to treat patients with severe bacterial infections requiring hospital treatment.
Abgentis
This company develops broad-spectrum antibacterial drugs for pharmaceutical firms to treat acute, chronic, and drug-resistant infections.
Evolutionary Genomics
This company provides a genomics research platform that identifies and validates genes for commercially valuable agricultural traits to serve seed companies and crop producers.
